Correction to “Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study”

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiet and metabolism studies · Gut microbiota and health · Genetic Associations and Epidemiology
H. Zheng, S. Wu, W. Wang, W. Qiu, Y. Feng. Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study. Journal of Clinical Hypertension 27 no. 1 (2025): e14968. https://doi.org/10.1111/jch.14968
The original version of this article was revised: changes include adjusting the author affiliation order and funding information to reflect updated institutional details.
The primary affiliation is now: “Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.” The secondary affiliation is “School of Medicine, South China University of Technology, Guangzhou, China.”
Funding statement was updated to: This work was supported by the Noncommunicable Chronic Diseases‐National Science and Technology Major Project of China (no. 2023ZD0508906 and no. 2024ZD0526803), The Climbing Plan of Guangdong Provincial People's Hospital (DFJH2020022), Guangdong Special Funds for Science and Technology Innovation Strategy (Stability support for scientific research institutions affiliated to Guangdong Province‐GDCI 2024), and The Key Area R&D Program of Guangdong Province (no. 2019B020227005).
We apologize for this error.
